Columbia Research Enhanced Small Cap ETF (RESM)
RESM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Aug. 28, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | · | · |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▼ -1.26% | ▼ -1.26% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 1,040 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Ring Energy Inc | 76680V108 | $360 | 0.01 | 333 | EC | US |
| Perspective Therapeutics Inc | 46489V302 | $358 | 0.01 | 105 | EC | US |
| Verastem Inc | 92337C203 | $355 | 0.01 | 93 | EC | US |
| Fulcrum Therapeutics Inc | 359616109 | $355 | 0.01 | 97 | EC | US |
| RE/MAX Holdings Inc | 75524W108 | $355 | 0.01 | 36 | EC | US |
| McGraw Hill Inc | 580907103 | $350 | 0.01 | 37 | EC | US |
| Akebia Therapeutics Inc | 00972D105 | $347 | 0.01 | 304 | EC | US |
| Eledon Pharmaceuticals Inc | 28617K101 | $339 | 0.01 | 86 | EC | US |
| Pangaea Logistics Solutions Ltd | · | $338 | 0.01 | 52 | EC | BM |
| Lexeo Therapeutics Inc | 52886X107 | $335 | 0.01 | 72 | EC | US |
| Compass Therapeutics Inc | 20454B104 | $326 | 0.01 | 149 | EC | US |
| Codexis Inc | 192005106 | $325 | 0.01 | 144 | EC | US |
| Immuneering Corp | 45254E107 | $324 | 0.01 | 65 | EC | US |
| RxSight Inc | 78349D107 | $323 | 0.01 | 67 | EC | US |
| MapLight Therapeutics Inc | 56565P103 | $323 | 0.01 | 9 | EC | US |
| Microvast Holdings Inc | 59516C106 | $310 | 0.01 | 265 | EC | US |
| Embecta Corp | 29082K105 | $306 | 0.01 | 94 | EC | US |
| Designer Brands Inc | 250565108 | $303 | 0.01 | 52 | EC | US |
| HMH Holding Inc | 40445M100 | $300 | 0.01 | 16 | EC | US |
| Evommune Inc | 30054Y107 | $292 | 0.01 | 22 | EC | US |
| Upstream Bio Inc | 91678A107 | $291 | 0.01 | 42 | EC | US |
| LifeMD Inc | 53216B104 | $281 | 0.01 | 68 | EC | US |
| Anavex Life Sciences Corp | 032797300 | $272 | 0.01 | 105 | EC | US |
| Atrium Therapeutics Inc | 04965N104 | $269 | 0.01 | 20 | EC | US |
| Zentalis Pharmaceuticals Inc | 98943L107 | $262 | 0.01 | 54 | EC | US |
| Angi Inc | 00183L201 | $256 | 0.01 | 43 | EC | US |
| Invivyd Inc | 00534A102 | $255 | 0.01 | 292 | EC | US |
| Tonix Pharmaceuticals Holding Corp | 890260839 | $242 | 0.01 | 19 | EC | US |
| HighPeak Energy Inc | 43114Q105 | $231 | 0.01 | 33 | EC | US |
| MNTN Inc | 55318A108 | $230 | 0.01 | 25 | EC | US |
| Karyopharm Therapeutics Inc | 48576U205 | $225 | 0.01 | 23 | EC | US |
| Keros Therapeutics Inc | 492327101 | $225 | 0.01 | 21 | EC | US |
| CONTRA TREEHOUSE FOODS | 894CVR018 | $184 | 0.01 | 105 | DE | US |
| Amplify Energy Corp | 03212B103 | $183 | 0.00 | 46 | EC | US |
| Larimar Therapeutics Inc | 517125100 | $180 | 0.00 | 59 | EC | US |
| PrimeEnergy Resources Corp | 74158E104 | $167 | 0.00 | 1 | EC | US |
| Lands' End Inc | 51509F105 | $147 | 0.00 | 14 | EC | US |
| Unicycive Therapeutics Inc | 90466Y202 | $131 | 0.00 | 28 | EC | US |
| CONTRA AVADEL PHARMACE | · | $131 | 0.00 | 238 | DE | IE |
| Infinity Natural Resources Inc | 456941103 | $51 | 0.00 | 4 | EC | US |
Sector breakdown
Dividends 1 payment
| Ex-date | Amount / share |
|---|---|
| Dec. 18, 2025 | $0.0190 |
Institutional owners (13F) 4 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| AMERIPRISE FINANCIAL INC | $2,990,503 | 83.44% | 122,354 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $420,000 | 11.72% | 17,179 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $141,760 | 3.96% | 5,800 | Shares | June 30, 2026 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | $31,774 | 0.89% | 1,300 | Shares | June 30, 2026 |